Chemoinformaics analysis of 1,4,9-Cadinatriene
| Molecular Weight | 202.341 | nRot | 1 |
| Heavy Atom Molecular Weight | 180.165 | nRig | 11 |
| Exact Molecular Weight | 202.172 | nRing | 2 |
| Solubility: LogS | -4.899 | nHRing | 0 |
| Solubility: LogP | 4.943 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 39.7194 |
| nHD | 0 | BPOL | 22.0706 |
| QED | 0.549 |
| Synth | 4.196 |
| Natural Product Likeliness | 2.423 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.925 |
| Pgp-sub | 0.002 |
| HIA | 0.006 |
| CACO-2 | -4.457 |
| MDCK | 0.0000129 |
| BBB | 0.393 |
| PPB | 0.959445 |
| VDSS | 4.209 |
| FU | 0.0346346 |
| CYP1A2-inh | 0.725 |
| CYP1A2-sub | 0.588 |
| CYP2c19-inh | 0.797 |
| CYP2c19-sub | 0.895 |
| CYP2c9-inh | 0.758 |
| CYP2c9-sub | 0.473 |
| CYP2d6-inh | 0.115 |
| CYP2d6-sub | 0.237 |
| CYP3a4-inh | 0.643 |
| CYP3a4-sub | 0.479 |
| CL | 10.713 |
| T12 | 0.091 |
| hERG | 0.037 |
| Ames | 0.012 |
| ROA | 0.054 |
| SkinSen | 0.914 |
| Carcinogencity | 0.297 |
| EI | 0.288 |
| Respiratory | 0.36 |
| NR-Aromatase | 0.005 |
| Antiviral | Yes |
| Prediction | 0.846764 |